Search

Author/Creator Perrotti, Danilo

1. Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop. Issue 6 (1st June 2013)

Authors:
van Etten, Richard A.; Mauro, Michael; Radich, Jerald P.; Goldman, John M.; Saglio, Giuseppe; Jamieson, Catriona; Soverini, Simona; Gambacorti-Passerini, Carlo; Hehlmann, Rüdiger; Martinelli, Giovanni; Perrotti, Danilo; Scadden, David T.; Skorski, Tomasz; Tefferi, Ayalew; Mughal, Tariq I.
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 6(2013:Jun.)
Page Start:
1151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop. Issue 6 (June 2013)

Authors:
van Etten, Richard A.; Mauro, Michael; Radich, Jerald P.; Goldman, John M.; Saglio, Giuseppe; Jamieson, Catriona; Soverini, Simona; Gambacorti-Passerini, Carlo; Hehlmann, Rüdiger; Martinelli, Giovanni; Perrotti, Danilo; Scadden, David T.; Skorski, Tomasz; Tefferi, Ayalew; Mughal, Tariq I.
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 6(2013:Jun.)
Page Start:
1151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms. Issue 5 (3rd August 2018)

Authors:
Mughal, Tariq I.; Lion, Thomas; Abdel‐Wahab, Omar; Mesa, Ruben; Scherber, Robyn M.; Perrotti, Danilo; Mauro, Michael; Verstovsek, Srdan; Saglio, Giuseppe; Van Etten, Richard A.; Kralovics, Robert
Journal:
Hematological oncology
Issue:
Volume 36:Issue 5(2018)
Page Start:
740
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis. Issue 1 (25th November 2012)

Authors:
Saddoughi, Sahar A.; Gencer, Salih; Peterson, Yuri K.; Ward, Katherine E.; Mukhopadhyay, Archana; Oaks, Joshua; Bielawski, Jacek; Szulc, Zdzislaw M.; Thomas, Raquela J.; Selvam, Shanmugam P.; Senkal, Can E.; Garrett‐Mayer, Elizabeth; De Palma, Ryan M.; Fedarovich, Dzmitry; Liu, Angen; Habib, Amyn...
Journal:
EMBO molecular medicine
Issue:
Volume 5:Issue 1(2013:Jan.)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis. Issue 1 (25th November 2012)

Authors:
Saddoughi, Sahar A.; Gencer, Salih; Peterson, Yuri K.; Ward, Katherine E.; Mukhopadhyay, Archana; Oaks, Joshua; Bielawski, Jacek; Szulc, Zdzislaw M.; Thomas, Raquela J.; Selvam, Shanmugam P.; Senkal, Can E.; Garrett‐Mayer, Elizabeth; De Palma, Ryan M.; Fedarovich, Dzmitry; Liu, Angen; Habib, Amyn...
Journal:
EMBO molecular medicine
Issue:
Volume 5:Issue 1(2013:Jan.)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗